* TELIGENT INC- EXPECT TO LAUNCH ERYTHROMYCIN TOPICAL SOLUTION USP, 2% BEFORE THE END 2017 Source text for Eikon: Further company coverage: ...
The FDA approves Teligent's (TLGT -0.6%) marketing application seeking approval for Erythromycin Topical Solution USP, 2%, the company's eighth approval this year and 18th overall. According to IQVIA, ...
Erythromycin is an antibiotic used to treat several kinds of bacterial infection. Erythromycin topical preparations are largely used on the skin to help control acne. The antibiotic drug is also used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results